Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (16330)	10/8/2003 11:58:26 AM
From: Cacaito	Respond to of 17367

Gw, YOU ASKED FOR IT ENDLESLY: small investigator sponsored trials are good, it means that the Fda is happy enough with safety issues to let the molecule run free around !!! And, I post already and repeat: YES, ODD could be a possibility, but there must be some administrative work on it, and they already got it for another indication (meningo)so it will be easy to apply, but it probably cost some money, they probably will way for some efficacy trend before applying, even better if someone else picks the tab!!!